Macrogenics Insider Trading Activity | NASDAQ:MGNX

Comments

Macrogenics Inc Insider Trading Activity

MGNXNASDAQ

Trade with Public

$3.48

0.020.58%

At close: Apr 20, 5:00 PM EST

$3.54

0.061.72%

After Hours: 5:10 PM EST

Overview News Earnings Options Analyst RatingsInsider TradesShort Interest Stock Report

Macrogenics Insider Trading Activity | NASDAQ:MGNX | Benzinga

Track the latest Macrogenics insider trading activity. Stay informed on recent buys, sells, and market impact for Macrogenics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Macrogenics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Macrogenics Inc

Shares Outstanding

63.556M

Shares Float

51730847.0%

Insider Shares Owned

1.838M

Insider Percentage Owned

2.91%

Institutional Shares Held

20.980M

Institutional Percentage Held

33.0%


Aug 21, 2025	WILLIAM HEIDEN	DIRECTOR	100.00K	$1.51	$150.51K	BUY	909.09%	111.00K	Aug 19 - Aug 20	View
Feb 19, 2025	Beth Smith	VP, CONTROLLER & TREASURER	672.00	$2.56	-$1.08K	SELL-OPTIONS	7.58%	9.53K	Feb 15	View
Apr 08, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-8.89K	$10.18	-$594.30K	SELL	-100.00%	0.00	Apr 04	View
Mar 08, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	0.00	$16.20	-$208.06K	SELL-OPTIONS	0.00%	8.89K	Mar 06	View
Mar 06, 2024	Blasius Eric Risser	CHIEF OPERATING OFFICER	-26.16K	$14.96	-$661.25K	SELL	-40.21%	38.90K	Mar 04	View
Mar 06, 2024	Thomas Spitznagel	SR VP, TECHNICAL OPS	0.00	$15.75	-$85.00K	SELL-OPTIONS	0.00%	8.32K	Mar 04	View
Mar 06, 2024	James Karrels	SVP, CFO AND SECRETARY	-30.00K	$20.50	-$615.00K	SELL	-14.89%	171.45K	Mar 04	View
Feb 28, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-16.12K	$17.22	-$277.66K	SELL	-64.45%	8.89K	Feb 26	View
Feb 07, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-3.33K	$18.00	-$60.01K	SELL	-4.47%	71.33K	Feb 07	View
Feb 07, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	0.00	$13.81	-$410.79K	SELL-OPTIONS	0.00%	0.00	Feb 05	View
Feb 02, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-13.32K	$15.00	-$199.74K	SELL	-15.13%	74.67K	Feb 01	View
Jan 22, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-13.32K	$12.00	-$159.79K	SELL	-13.15%	87.98K	Jan 19	View
Dec 21, 2023	Ezio Bonvini	SR VP, RESEARCH & CSO	-18.88K	$10.08	-$190.31K	SELL	-15.71%	101.30K	Dec 20	View
Oct 04, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	150.00K	$4.46	$669.59K	BUY	1.53%	9.93M	Oct 02	View
Sep 11, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$5.26	$1.05M	BUY	2.09%	9.78M	Sep 07	View
Sep 01, 2023	EDWARD HURWITZ	DIRECTOR	15.00K	$4.91	$73.65K	BUY	82.99%	33.07K	Aug 30	View
Mar 14, 2023	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-5.37K	$6.03	-$32.39K	SELL	-100.00%	0.00	Mar 10	View
Feb 16, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	500.00K	$5.07	$2.53M	BUY	5.51%	9.58M	Feb 14	View
Jan 23, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	150.00K	$5.30	$794.92K	BUY	1.68%	9.08M	Jan 19	View
Dec 28, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	400.00K	$5.75	$2.30M	BUY	4.69%	8.93M	Dec 23 - Dec 27	View
Nov 25, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	300.00K	$5.96	$1.79M	BUY	3.65%	8.53M	Nov 22	View
Oct 25, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	500.00K	$4.50	$2.25M	BUY	6.47%	8.23M	Oct 21 - Oct 24	View
Oct 21, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	454.40K	$3.89	$1.77M	BUY	6.25%	7.73M	Oct 19 - Oct 20	View
Jun 17, 2022	James Karrels	SVP, CFO AND SECRETARY	40.00K	$2.47	$98.80K	BUY	26.35%	191.78K	Jun 15	View
Nov 23, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$18.50	$3.70M	BUY	2.83%	7.28M	Nov 19	View
Sep 30, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$20.56	$4.11M	BUY	2.91%	7.08M	Sep 28 - Sep 29	View
Sep 20, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	600.00K	$20.61	$12.36M	BUY	9.56%	6.88M	Sep 16 - Sep 17	View
Jul 20, 2021	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$16.26	-$87.50K	SELL-OPTIONS	0.00%	0.00	Jul 16	View
Jun 23, 2021	TARGET BIOTECH V AG BIOTECH BB	10% OWNER	75.00K	$21.74	$1.63M	BUY	1.21%	6.28M	Jun 21	View
Jun 17, 2021	TARGET BIOTECH V AG BIOTECH BB	10% OWNER	175.00K	$20.82	$3.64M	BUY	2.90%	6.20M	Jun 15 - Jun 16	View
Apr 19, 2021	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$19.21	-$117.00K	SELL-OPTIONS	0.00%	0.00	Apr 15	View
Mar 24, 2021	James Karrels	SVP, CFO AND SECRETARY	-15.00K	$33.00	-$495.00K	SELL	-9.47%	143.46K	Mar 22	View
Mar 24, 2021	Ezio Bonvini	SR VP, RESEARCH & CSO	-3.92K	$32.00	-$125.34K	SELL	-4.67%	79.89K	Mar 22	View
Mar 09, 2021	Stuart Jeffrey Peters	GENERAL COUNSEL	0.00	$19.00	-$326.24K	SELL-OPTIONS	0.00%	0.00	Mar 08	View
Dec 30, 2020	Blasius Eric Risser	—	0.00	$12.81	-$11.29K	OPTION EXERCISE	0.00%	44.47K	Dec 29	View
Dec 01, 2020	Blasius Eric Risser	—	0.00	$12.43	-$10.92K	OPTION EXERCISE	0.00%	44.47K	Nov 30	View
Oct 29, 2020	Blasius Eric Risser	—	0.00	$11.10	-$28.77K	OPTION EXERCISE	0.00%	44.47K	Oct 28	View
Sep 29, 2020	Blasius Eric Risser	—	0.00	$13.42	-$11.91K	OPTION EXERCISE	0.00%	44.47K	Sep 28	View
Sep 21, 2020	Ezio Bonvini	—	-62.85K	$30.50	-$1.92M	SELL	-42.86%	83.81K	Sep 17 - Sep 18	View
Sep 10, 2020	Kenneth Galbraith	—	0.00	$22.25	-$202.05K	OPTION EXERCISE	0.00%	0.00	Sep 09	View
Aug 27, 2020	Blasius Eric Risser	—	0.00	$14.30	-$12.79K	OPTION EXERCISE	0.00%	44.47K	Aug 26	View
Aug 21, 2020	Thomas Spitznagel	—	0.00	$17.19	-$145.20K	OPTION EXERCISE	0.00%	0.00	Aug 20	View
Jul 28, 2020	Blasius Eric Risser	—	0.00	$13.46	-$107.82K	OPTION EXERCISE	0.00%	44.47K	Jul 27	View
Jul 06, 2020	Stuart Jeffrey Peters	—	-202.00	$30.00	-$6.06K	SELL	-100.00%	0.00	Jul 02	View
Jul 06, 2020	Blasius Eric Risser	—	0.00	$15.76	-$88.32K	OPTION EXERCISE	0.00%	44.47K	Jul 02	View
Jun 25, 2020	Blasius Eric Risser	—	0.00	$14.71	-$13.78K	OPTION EXERCISE	0.00%	44.47K	Jun 24	View
May 27, 2020	Blasius Eric Risser	—	0.00	$13.77	-$12.82K	OPTION EXERCISE	0.00%	44.47K	May 26	View
May 21, 2020	Thomas Spitznagel	—	0.00	$16.41	-$133.43K	OPTION EXERCISE	0.00%	0.00	May 20	View
May 07, 2020	Blasius Eric Risser	—	0.00	$11.21	-$156.46K	OPTION EXERCISE	0.00%	44.47K	May 06	View
Feb 21, 2020	Blasius Eric Risser	—	0.00	$5.89	-$4.95K	OPTION EXERCISE	0.00%	32.47K	Feb 20	View
Feb 06, 2020	Blasius Eric Risser	—	0.00	$5.47	-$5.92K	OPTION EXERCISE	0.00%	32.47K	Feb 04 - Feb 05	View
May 22, 2019	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$9.74	-$70.40K	SELL-OPTIONS	0.00%	30.81K	May 20 - May 22	View
Feb 08, 2019	Matthew Fust	DIRECTOR	0.00	$24.76	-$63.91K	SELL-OPTIONS	0.00%	500.00	Feb 06	View
Feb 08, 2019	Stuart Jeffrey Peters	GENERAL COUNSEL	-68.00	$30.00	-$2.04K	SELL	-25.19%	202.00	Feb 06	View
Feb 08, 2019	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$18.75	-$39.81K	SELL-OPTIONS	0.00%	0.00	Feb 06	View
Mar 14, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$16.01	-$30.14K	SELL-OPTIONS	0.00%	9.10K	Mar 12	View
Mar 07, 2018	James Karrels	SVP, CFO AND SECRETARY	-5.00K	$31.00	-$155.00K	SELL	-4.17%	114.85K	Mar 05	View
Mar 06, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$15.47	-$116.24K	SELL-OPTIONS	0.00%	9.10K	Mar 02	View
Mar 01, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$12.97	-$24.07K	SELL-OPTIONS	0.00%	9.10K	Feb 28	View
Mar 01, 2018	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$13.07	-$572.35K	SELL-OPTIONS	0.00%	1.92K	Feb 28	View
Jan 25, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$11.72	-$64.68K	SELL-OPTIONS	0.00%	9.10K	Jan 24	View
Jan 18, 2018	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Jan 16 - Jan 17	View
Nov 21, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Nov 21	View
Oct 26, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$153.00K	SELL-OPTIONS	0.00%	30.00K	Oct 25	View
Jun 06, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Jun 05	View
Apr 20, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$229.50K	SELL-OPTIONS	0.00%	30.00K	Apr 19	View
Oct 05, 2016	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$17.02	-$246.40K	SELL-OPTIONS	0.00%	0.00	Oct 03	View
Oct 05, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$15.11	-$176.59K	SELL-OPTIONS	0.00%	1.92K	Oct 03	View
Aug 03, 2016	Marc Jon Wigginton	SR VP CLINICAL DEV & CMO	0.00	$17.74	-$521.60K	SELL-OPTIONS	0.00%	0.00	Aug 01	View
Jul 06, 2016	Marc Jon Wigginton	SR VP CLINICAL DEV & CMO	0.00	$15.96	-$112.60K	SELL-OPTIONS	0.00%	0.00	Jul 01	View
Jul 06, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$14.08	-$234.47K	SELL-OPTIONS	0.00%	1.92K	Jul 01	View
May 27, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$12.97	-$120.30K	SELL-OPTIONS	0.00%	1.92K	May 27	View
Mar 04, 2016	Paulo Costa	DIRECTOR	10.00K	$17.20	$172.00K	BUY	20.23%	59.44K	Mar 03	View
Jan 06, 2016	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.17	-$249.40K	SELL-OPTIONS	0.00%	0.00	Jan 04	View
Nov 24, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-1.92K	$17.97	-$237.53K	SELL	-49.97%	1.92K	Jul 01 - Nov 23	View
Nov 17, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-3.12K	$31.44	-$98.00K	SELL	-4.24%	70.32K	Nov 16	View
Oct 19, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-6.23K	$25.21	-$157.13K	SELL	-7.82%	73.43K	Oct 15	View
Oct 02, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$12.90	-$82.05K	SELL-OPTIONS	0.00%	0.00	Oct 01	View
Aug 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$20.93	-$324.50K	SELL-OPTIONS	0.00%	0.00	Aug 03	View
Jul 13, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$19.40	-$89.71K	SELL-OPTIONS	0.00%	36.79K	Jul 10	View
Jul 01, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-1.92K	$19.04	-$252.42K	SELL	-33.32%	3.84K	Jul 01	View
Jul 01, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$20.93	-$162.25K	SELL-OPTIONS	0.00%	0.00	Jul 01	View
Jul 01, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$19.39	-$242.73K	SELL-OPTIONS	0.00%	36.79K	Jun 30	View
Jun 25, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-6.10K	$38.08	-$232.17K	SELL	-25.69%	17.64K	Jun 24	View
Jun 24, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-13.05K	$38.14	-$497.88K	SELL	-35.48%	23.74K	Jun 23	View
Jun 16, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-5.70K	$17.97	-$369.80K	SELL	-49.72%	5.76K	Jun 15	View
Jun 16, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$17.36	-$207.56K	SELL-OPTIONS	0.00%	36.79K	Jun 15	View
May 18, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$15.47	-$184.06K	SELL-OPTIONS	0.00%	36.79K	May 15	View
Apr 16, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$17.34	-$207.37K	SELL-OPTIONS	0.00%	36.79K	Apr 15	View
Apr 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.78	-$130.80K	SELL-OPTIONS	0.00%	0.00	Apr 01	View
Feb 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.87	-$131.70K	SELL-OPTIONS	0.00%	0.00	Feb 02	View
Dec 23, 2014	Kathryn Stein	SVP, PRODUCT DEV. & REGULATORY	0.00	$18.54	-$404.22K	SELL-OPTIONS	0.00%	43.20K	Dec 22	View
Dec 22, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$17.22	-$325.60K	SELL-OPTIONS	0.00%	0.00	Dec 18	View
Dec 22, 2014	Kathryn Stein	SVP, PRODUCT DEV. & REGULATORY	0.00	$16.86	-$353.45K	SELL-OPTIONS	0.00%	43.20K	Dec 18	View
Nov 25, 2014	Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$14.35	-$268.10K	SELL-OPTIONS	0.00%	0.00	Nov 24	View
Nov 24, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$13.86	-$287.77K	SELL-OPTIONS	0.00%	43.20K	Nov 21	View
Nov 17, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$12.12	-$565.70K	SELL-OPTIONS	0.00%	43.20K	Nov 14 - Nov 17	View
Nov 13, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	-5.00K	$12.37	-$576.20K	SELL	-100.00%	0.00	Nov 12 - Nov 13	View
Oct 02, 2014	Marc Jon Wigginton	SR V.P., CLINICAL	0.00	$12.59	-$78.90K	SELL-OPTIONS	0.00%	0.00	Oct 01	View
Sep 02, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	-8.32K	$20.89	-$173.72K	SELL	-62.45%	5.00K	Sep 02	View
Aug 19, 2014	Marc Jon Wigginton	SENIOR VP, CLINICAL DEV.	0.00	$12.61	-$79.10K	SELL-OPTIONS	0.00%	0.00	Aug 18	View
Jul 01, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$11.39	-$167.20K	SELL-OPTIONS	0.00%	13.32K	Jun 30	View
May 30, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$10.23	-$208.41K	SELL-OPTIONS	0.00%	43.20K	May 29	View
Feb 18, 2014	EDWARD HURWITZ	DIRECTOR	-308.51K	$36.50	-$11.26M	SELL	-15.32%	1.70M	Feb 18	View
Feb 18, 2014	ARNOLD ORONSKY	DIRECTOR	-200.00K	$36.50	-$7.30M	SELL	-10.48%	1.71M	Feb 18	View
Oct 18, 2013	Kenneth Galbraith	DIRECTOR	1.32M	$16.00	$750.00K	BUY	∞	1.32M	Oct 16	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

US crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying

The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

PRO
Macrogenics Shares See Volume; Co Reports In Form4 Filing Biotech Target Buys 200K Shares At Average Price Of $18.50/Share

-SEC Filing

Benzinga Newsdesk

People Also Watch

Atrium Therapeutics Inc

NASDAQ:RNA

$14.30

Voyager Therapeutics Inc

NASDAQ:VYGR

$4.23

ProQR Therapeutics NV

NASDAQ:PRQR

$1.83

-0.55%

Burning Rock Biotech Ltd

Elicio Therapeutics Inc

NASDAQ:ELTX

$12.62

3.33%

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$4.20

-0.71%

Anika Therapeutics Inc

NASDAQ:ANIK

$15.82


Aug 21, 2025	WILLIAM HEIDEN	DIRECTOR	100.00K	$1.51	$150.51K	BUY	909.09%	111.00K	Aug 19 - Aug 20	View
Feb 19, 2025	Beth Smith	VP, CONTROLLER & TREASURER	672.00	$2.56	-$1.08K	SELL-OPTIONS	7.58%	9.53K	Feb 15	View
Apr 08, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-8.89K	$10.18	-$594.30K	SELL	-100.00%	0.00	Apr 04	View
Mar 08, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	0.00	$16.20	-$208.06K	SELL-OPTIONS	0.00%	8.89K	Mar 06	View
Mar 06, 2024	Blasius Eric Risser	CHIEF OPERATING OFFICER	-26.16K	$14.96	-$661.25K	SELL	-40.21%	38.90K	Mar 04	View
Mar 06, 2024	Thomas Spitznagel	SR VP, TECHNICAL OPS	0.00	$15.75	-$85.00K	SELL-OPTIONS	0.00%	8.32K	Mar 04	View
Mar 06, 2024	James Karrels	SVP, CFO AND SECRETARY	-30.00K	$20.50	-$615.00K	SELL	-14.89%	171.45K	Mar 04	View
Feb 28, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-16.12K	$17.22	-$277.66K	SELL	-64.45%	8.89K	Feb 26	View
Feb 07, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-3.33K	$18.00	-$60.01K	SELL	-4.47%	71.33K	Feb 07	View
Feb 07, 2024	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	0.00	$13.81	-$410.79K	SELL-OPTIONS	0.00%	0.00	Feb 05	View
Feb 02, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-13.32K	$15.00	-$199.74K	SELL	-15.13%	74.67K	Feb 01	View
Jan 22, 2024	Ezio Bonvini	SR VP, RESEARCH & CSO	-13.32K	$12.00	-$159.79K	SELL	-13.15%	87.98K	Jan 19	View
Dec 21, 2023	Ezio Bonvini	SR VP, RESEARCH & CSO	-18.88K	$10.08	-$190.31K	SELL	-15.71%	101.30K	Dec 20	View
Oct 04, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	150.00K	$4.46	$669.59K	BUY	1.53%	9.93M	Oct 02	View
Sep 11, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$5.26	$1.05M	BUY	2.09%	9.78M	Sep 07	View
Sep 01, 2023	EDWARD HURWITZ	DIRECTOR	15.00K	$4.91	$73.65K	BUY	82.99%	33.07K	Aug 30	View
Mar 14, 2023	Stuart Jeffrey Peters	SENIOR VP AND GENERAL COUNSEL	-5.37K	$6.03	-$32.39K	SELL	-100.00%	0.00	Mar 10	View
Feb 16, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	500.00K	$5.07	$2.53M	BUY	5.51%	9.58M	Feb 14	View
Jan 23, 2023	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	150.00K	$5.30	$794.92K	BUY	1.68%	9.08M	Jan 19	View
Dec 28, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	400.00K	$5.75	$2.30M	BUY	4.69%	8.93M	Dec 23 - Dec 27	View
Nov 25, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	300.00K	$5.96	$1.79M	BUY	3.65%	8.53M	Nov 22	View
Oct 25, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	500.00K	$4.50	$2.25M	BUY	6.47%	8.23M	Oct 21 - Oct 24	View
Oct 21, 2022	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	454.40K	$3.89	$1.77M	BUY	6.25%	7.73M	Oct 19 - Oct 20	View
Jun 17, 2022	James Karrels	SVP, CFO AND SECRETARY	40.00K	$2.47	$98.80K	BUY	26.35%	191.78K	Jun 15	View
Nov 23, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$18.50	$3.70M	BUY	2.83%	7.28M	Nov 19	View
Sep 30, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	200.00K	$20.56	$4.11M	BUY	2.91%	7.08M	Sep 28 - Sep 29	View
Sep 20, 2021	TARGET BIOTECH V BB BIOTECH AG	10% OWNER	600.00K	$20.61	$12.36M	BUY	9.56%	6.88M	Sep 16 - Sep 17	View
Jul 20, 2021	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$16.26	-$87.50K	SELL-OPTIONS	0.00%	0.00	Jul 16	View
Jun 23, 2021	TARGET BIOTECH V AG BIOTECH BB	10% OWNER	75.00K	$21.74	$1.63M	BUY	1.21%	6.28M	Jun 21	View
Jun 17, 2021	TARGET BIOTECH V AG BIOTECH BB	10% OWNER	175.00K	$20.82	$3.64M	BUY	2.90%	6.20M	Jun 15 - Jun 16	View
Apr 19, 2021	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$19.21	-$117.00K	SELL-OPTIONS	0.00%	0.00	Apr 15	View
Mar 24, 2021	James Karrels	SVP, CFO AND SECRETARY	-15.00K	$33.00	-$495.00K	SELL	-9.47%	143.46K	Mar 22	View
Mar 24, 2021	Ezio Bonvini	SR VP, RESEARCH & CSO	-3.92K	$32.00	-$125.34K	SELL	-4.67%	79.89K	Mar 22	View
Mar 09, 2021	Stuart Jeffrey Peters	GENERAL COUNSEL	0.00	$19.00	-$326.24K	SELL-OPTIONS	0.00%	0.00	Mar 08	View
Dec 30, 2020	Blasius Eric Risser	—	0.00	$12.81	-$11.29K	OPTION EXERCISE	0.00%	44.47K	Dec 29	View
Dec 01, 2020	Blasius Eric Risser	—	0.00	$12.43	-$10.92K	OPTION EXERCISE	0.00%	44.47K	Nov 30	View
Oct 29, 2020	Blasius Eric Risser	—	0.00	$11.10	-$28.77K	OPTION EXERCISE	0.00%	44.47K	Oct 28	View
Sep 29, 2020	Blasius Eric Risser	—	0.00	$13.42	-$11.91K	OPTION EXERCISE	0.00%	44.47K	Sep 28	View
Sep 21, 2020	Ezio Bonvini	—	-62.85K	$30.50	-$1.92M	SELL	-42.86%	83.81K	Sep 17 - Sep 18	View
Sep 10, 2020	Kenneth Galbraith	—	0.00	$22.25	-$202.05K	OPTION EXERCISE	0.00%	0.00	Sep 09	View
Aug 27, 2020	Blasius Eric Risser	—	0.00	$14.30	-$12.79K	OPTION EXERCISE	0.00%	44.47K	Aug 26	View
Aug 21, 2020	Thomas Spitznagel	—	0.00	$17.19	-$145.20K	OPTION EXERCISE	0.00%	0.00	Aug 20	View
Jul 28, 2020	Blasius Eric Risser	—	0.00	$13.46	-$107.82K	OPTION EXERCISE	0.00%	44.47K	Jul 27	View
Jul 06, 2020	Stuart Jeffrey Peters	—	-202.00	$30.00	-$6.06K	SELL	-100.00%	0.00	Jul 02	View
Jul 06, 2020	Blasius Eric Risser	—	0.00	$15.76	-$88.32K	OPTION EXERCISE	0.00%	44.47K	Jul 02	View
Jun 25, 2020	Blasius Eric Risser	—	0.00	$14.71	-$13.78K	OPTION EXERCISE	0.00%	44.47K	Jun 24	View
May 27, 2020	Blasius Eric Risser	—	0.00	$13.77	-$12.82K	OPTION EXERCISE	0.00%	44.47K	May 26	View
May 21, 2020	Thomas Spitznagel	—	0.00	$16.41	-$133.43K	OPTION EXERCISE	0.00%	0.00	May 20	View
May 07, 2020	Blasius Eric Risser	—	0.00	$11.21	-$156.46K	OPTION EXERCISE	0.00%	44.47K	May 06	View
Feb 21, 2020	Blasius Eric Risser	—	0.00	$5.89	-$4.95K	OPTION EXERCISE	0.00%	32.47K	Feb 20	View
Feb 06, 2020	Blasius Eric Risser	—	0.00	$5.47	-$5.92K	OPTION EXERCISE	0.00%	32.47K	Feb 04 - Feb 05	View
May 22, 2019	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$9.74	-$70.40K	SELL-OPTIONS	0.00%	30.81K	May 20 - May 22	View
Feb 08, 2019	Matthew Fust	DIRECTOR	0.00	$24.76	-$63.91K	SELL-OPTIONS	0.00%	500.00	Feb 06	View
Feb 08, 2019	Stuart Jeffrey Peters	GENERAL COUNSEL	-68.00	$30.00	-$2.04K	SELL	-25.19%	202.00	Feb 06	View
Feb 08, 2019	Thomas Spitznagel	SR VP, BPD & MANUFACTURING	0.00	$18.75	-$39.81K	SELL-OPTIONS	0.00%	0.00	Feb 06	View
Mar 14, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$16.01	-$30.14K	SELL-OPTIONS	0.00%	9.10K	Mar 12	View
Mar 07, 2018	James Karrels	SVP, CFO AND SECRETARY	-5.00K	$31.00	-$155.00K	SELL	-4.17%	114.85K	Mar 05	View
Mar 06, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$15.47	-$116.24K	SELL-OPTIONS	0.00%	9.10K	Mar 02	View
Mar 01, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$12.97	-$24.07K	SELL-OPTIONS	0.00%	9.10K	Feb 28	View
Mar 01, 2018	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$13.07	-$572.35K	SELL-OPTIONS	0.00%	1.92K	Feb 28	View
Jan 25, 2018	Blasius Eric Risser	SR VP & CHIEF BUSINESS OFFICER	0.00	$11.72	-$64.68K	SELL-OPTIONS	0.00%	9.10K	Jan 24	View
Jan 18, 2018	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Jan 16 - Jan 17	View
Nov 21, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Nov 21	View
Oct 26, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$153.00K	SELL-OPTIONS	0.00%	30.00K	Oct 25	View
Jun 06, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$76.50K	SELL-OPTIONS	0.00%	30.00K	Jun 05	View
Apr 20, 2017	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$12.35	-$229.50K	SELL-OPTIONS	0.00%	30.00K	Apr 19	View
Oct 05, 2016	Marc Jon Wigginton	SR VP, CLINICAL DEV. & CMO	0.00	$17.02	-$246.40K	SELL-OPTIONS	0.00%	0.00	Oct 03	View
Oct 05, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$15.11	-$176.59K	SELL-OPTIONS	0.00%	1.92K	Oct 03	View
Aug 03, 2016	Marc Jon Wigginton	SR VP CLINICAL DEV & CMO	0.00	$17.74	-$521.60K	SELL-OPTIONS	0.00%	0.00	Aug 01	View
Jul 06, 2016	Marc Jon Wigginton	SR VP CLINICAL DEV & CMO	0.00	$15.96	-$112.60K	SELL-OPTIONS	0.00%	0.00	Jul 01	View
Jul 06, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$14.08	-$234.47K	SELL-OPTIONS	0.00%	1.92K	Jul 01	View
May 27, 2016	Lynn Cilinski	VP, CONTROLLER AND TREASURER	0.00	$12.97	-$120.30K	SELL-OPTIONS	0.00%	1.92K	May 27	View
Mar 04, 2016	Paulo Costa	DIRECTOR	10.00K	$17.20	$172.00K	BUY	20.23%	59.44K	Mar 03	View
Jan 06, 2016	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.17	-$249.40K	SELL-OPTIONS	0.00%	0.00	Jan 04	View
Nov 24, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-1.92K	$17.97	-$237.53K	SELL	-49.97%	1.92K	Jul 01 - Nov 23	View
Nov 17, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-3.12K	$31.44	-$98.00K	SELL	-4.24%	70.32K	Nov 16	View
Oct 19, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-6.23K	$25.21	-$157.13K	SELL	-7.82%	73.43K	Oct 15	View
Oct 02, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$12.90	-$82.05K	SELL-OPTIONS	0.00%	0.00	Oct 01	View
Aug 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$20.93	-$324.50K	SELL-OPTIONS	0.00%	0.00	Aug 03	View
Jul 13, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$19.40	-$89.71K	SELL-OPTIONS	0.00%	36.79K	Jul 10	View
Jul 01, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-1.92K	$19.04	-$252.42K	SELL	-33.32%	3.84K	Jul 01	View
Jul 01, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$20.93	-$162.25K	SELL-OPTIONS	0.00%	0.00	Jul 01	View
Jul 01, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$19.39	-$242.73K	SELL-OPTIONS	0.00%	36.79K	Jun 30	View
Jun 25, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-6.10K	$38.08	-$232.17K	SELL	-25.69%	17.64K	Jun 24	View
Jun 24, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	-13.05K	$38.14	-$497.88K	SELL	-35.48%	23.74K	Jun 23	View
Jun 16, 2015	Lynn Cilinski	VP, CONTROLLER AND TREASURER	-5.70K	$17.97	-$369.80K	SELL	-49.72%	5.76K	Jun 15	View
Jun 16, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$17.36	-$207.56K	SELL-OPTIONS	0.00%	36.79K	Jun 15	View
May 18, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$15.47	-$184.06K	SELL-OPTIONS	0.00%	36.79K	May 15	View
Apr 16, 2015	Ezio Bonvini	SENIOR VP, RESEARCH	0.00	$17.34	-$207.37K	SELL-OPTIONS	0.00%	36.79K	Apr 15	View
Apr 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.78	-$130.80K	SELL-OPTIONS	0.00%	0.00	Apr 01	View
Feb 03, 2015	Marc Jon Wigginton	SR VP, CLINICAL	0.00	$17.87	-$131.70K	SELL-OPTIONS	0.00%	0.00	Feb 02	View
Dec 23, 2014	Kathryn Stein	SVP, PRODUCT DEV. & REGULATORY	0.00	$18.54	-$404.22K	SELL-OPTIONS	0.00%	43.20K	Dec 22	View
Dec 22, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$17.22	-$325.60K	SELL-OPTIONS	0.00%	0.00	Dec 18	View
Dec 22, 2014	Kathryn Stein	SVP, PRODUCT DEV. & REGULATORY	0.00	$16.86	-$353.45K	SELL-OPTIONS	0.00%	43.20K	Dec 18	View
Nov 25, 2014	Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$14.35	-$268.10K	SELL-OPTIONS	0.00%	0.00	Nov 24	View
Nov 24, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$13.86	-$287.77K	SELL-OPTIONS	0.00%	43.20K	Nov 21	View
Nov 17, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$12.12	-$565.70K	SELL-OPTIONS	0.00%	43.20K	Nov 14 - Nov 17	View
Nov 13, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	-5.00K	$12.37	-$576.20K	SELL	-100.00%	0.00	Nov 12 - Nov 13	View
Oct 02, 2014	Marc Jon Wigginton	SR V.P., CLINICAL	0.00	$12.59	-$78.90K	SELL-OPTIONS	0.00%	0.00	Oct 01	View
Sep 02, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	-8.32K	$20.89	-$173.72K	SELL	-62.45%	5.00K	Sep 02	View
Aug 19, 2014	Marc Jon Wigginton	SENIOR VP, CLINICAL DEV.	0.00	$12.61	-$79.10K	SELL-OPTIONS	0.00%	0.00	Aug 18	View
Jul 01, 2014	Blasius Eric Risser	VP, BUSINESS DEVELOPMENT	0.00	$11.39	-$167.20K	SELL-OPTIONS	0.00%	13.32K	Jun 30	View
May 30, 2014	Kathryn Stein	SENIOR VP, PRD DEV & REG AFF	0.00	$10.23	-$208.41K	SELL-OPTIONS	0.00%	43.20K	May 29	View
Feb 18, 2014	EDWARD HURWITZ	DIRECTOR	-308.51K	$36.50	-$11.26M	SELL	-15.32%	1.70M	Feb 18	View
Feb 18, 2014	ARNOLD ORONSKY	DIRECTOR	-200.00K	$36.50	-$7.30M	SELL	-10.48%	1.71M	Feb 18	View
Oct 18, 2013	Kenneth Galbraith	DIRECTOR	1.32M	$16.00	$750.00K	BUY	∞	1.32M	Oct 16	View

Macrogenics Inc Insider Trading Activity

Macrogenics Insider Trading Activity | NASDAQ:MGNX | Benzinga

What is Insider Activity?

What are Macrogenics Inc Insiders Doing?

Notable Recent Insider Buys and Sales

Ownership Statistics for Macrogenics Inc

FAQ

Is insider trading legal?

What are some examples of market manipulation?

MGNX Insider Trading News

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying

$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying

$7.5 Million Bet On Local Bounti? Check Out These 3 Penny Stocks Insiders Are Buying

$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying

PRO
Macrogenics Shares See Volume; Co Reports In Form4 Filing Biotech Target Buys 200K Shares At Average Price Of $18.50/Share

People Also Watch

Benzinga

Benzinga

Macrogenics Inc Insider Trading Activity

Macrogenics Insider Trading Activity | NASDAQ:MGNX | Benzinga

What is Insider Activity?

What are Macrogenics Inc Insiders Doing?

Notable Recent Insider Buys and Sales

Ownership Statistics for Macrogenics Inc

FAQ

Is insider trading legal?

What are some examples of market manipulation?

MGNX Insider Trading News

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying

$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying

$7.5 Million Bet On Local Bounti? Check Out These 3 Penny Stocks Insiders Are Buying

$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying

PROMacrogenics Shares See Volume; Co Reports In Form4 Filing Biotech Target Buys 200K Shares At Average Price Of $18.50/Share

People Also Watch

PRO
Macrogenics Shares See Volume; Co Reports In Form4 Filing Biotech Target Buys 200K Shares At Average Price Of $18.50/Share